Search Results - Kuppen, MCP

  • Showing 1 - 1 results of 1
Refine Results
  1. 1
    POSC399 Treatment Effect and Costs of the Complete Therapeutic Pathway in Patients with First-Line Castration-Resistant Prostate Cancer with Either First-Line Docetaxel or Abiraterone Acetate Plus Prednisone

    POSC399 Treatment Effect and Costs of the Complete Therapeutic Pathway in Patients with First-Line Castration-Resistant Prostate Cancer with Either First-Line Docetaxel or Abirater... by Holleman, MS, Santi, I, Huygens, S, Aben, KKH, Van den Bergh, ACM, Bergman, AM, van den Eertwegh, AJM, Kuppen, MCP, Lavalaye, J, Mehra, NM, van Moorselaar, RJA, Van Oort, IM, Somford, DM, Westgeest, HM, Gerritsen, WR, Uyl-De Groot, CA

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: